COVID-19 Reinfection in a Patient with Hodgkin Lymphoma: a Case Report

Atefeh Fakharian; Hamed Ebrahimibagha; Maryam Sadaat Mirenayat; Fargol Farahmandi

COVID-19 Reinfection in a Patient with Hodgkin Lymphoma: a Case Report

Tanaffos. 2021 Jan;20(1):71-74.

Authors

Atefeh Fakharian¹, Hamed Ebrahimibagha², Maryam Sadaat Mirenayat¹, Fargol Farahmandi²

Affiliations

¹ Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
² Medical Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 34394373
PMCID: PMC8355931

Abstract

COVID-19 pneumonia has invaded the world and continues to expand. The current evidence of the immune system reaction to this viral pneumonia shows that the post-infectious immunity against the virus may be temporary, and the virus may reinfect the patients after healing from the previous one. Here is presented a 55-year-old female patient, as a known case of Hodgkin lymphoma, diagnosed with COVID-19 reinfection during 40 days. Such evidence may be helpful in further understanding the immunology of the disease.

Keywords: COVID-19; Hodgkin Lymphoma; Reinfection.

Publication types

Case Reports